Article info
Extended reports
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis
- Correspondence to:
Dr S H Polmar
Therapeutic Area Immunology, Boehringer Ingelheim Pharmaceuticals, 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA; spolmar{at}rdg.boehringer-ingelheim.com
Citation
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis
Publication history
- Accepted December 2, 2006
- First published December 14, 2006.
Online issue publication
April 27, 2007
Article Versions
- Previous version (14 December 2006).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Annals of the Rheumatic Diseases